Moderna shares down after pulling Covid-flu combo vaccine application
Moderna has “voluntarily” withdrawn its application to the US Food and Drug Administration (FDA) for approval of its Covid-19 and…
News
Viz.ai, Sanofi and Regeneron to link for COPD management
WHO secures 20% funding increase amid US shortfall
BioNTech to invest up to $1.34bn in UK R&D
FDA to restrict Covid-19 booster doses to older adults
HHS sets “most favoured nation” pricing targets for drug makers
Skye and Arecor to develop higher formulation of CB1 inhibitor
Countries formally adopt WHO’s Pandemic Agreement for future pandemics
